A Q&A with David Williams, Chief Medical Officer, VISFO
Since its publication in the journal of Therapeutic Innovation & Regulatory Science in July, the article “Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS,” has been read more than 4000 times. This article presents highlights from a recent MAPS webinar with the paper’s authors, focusing on further defining the role and best practices for Medical Science Liaisons.
Near the end of Jill Donahue’s family trip to Greece, an unlicensed tour guide, Charis, showed what communication mastery looks like.
MAPS speaks with MyHealthTeams Cofounder and CEO, Eric Peacock, about how health communities can help the biopharmaceutical industry develop new products that truly make a difference in patients’ lives.
This paper addresses the complexities of prioritizing contemporary journal offerings to accomplish article objectives and overall publication planning goals.
This article explores the neuroscience of success and how a different, more thought-out approach to our behavior in the workplace can lead to higher chances of career success in the long run.
MAPS speaks with leaders from Lundbeck, Biogen, BMS and Medline about new best practices for the product launch planning process.
Placing more focus on self-development and knowledge acquisition is imperative for Medical Affairs professionals of tomorrow — making proper coaching crucial for MA leaders.
Here we explore how some of the top Medical Affairs leaders from Johnson & Johnson think about evolving from a highly skilled individual contributor to a people leader.
This Q&A describes Amgen Europe HCP preference survey results and wider changes in the way MSLs will work with their HCP peers as we emerge from the pandemic.